Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|October 31, 2015
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backboneChristian Krug, Katrin Birkholz, Alexander Paulus, et al.
Frontiers in Immunology|September 4, 2023
Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionalityFelix Pfister, Jan Dörrie, Niels Schaft, et al.
Plos One|October 8, 2014
Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantationJan Dörrie, Christian Krug, Christian Hofmann, et al.
Journal of Immunological Methods|April 19, 2012
HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patientsJennifer K Etschel, Angela G Hückelhoven, Christian Hofmann, et al.
Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.
Cytotherapy|April 14, 2015
Selection of adenovirus-specific and Epstein-Barr virus-specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)-compliant conditionsChristine Freimüller, Julia Stemberger, Michaela Artwohl, et al.
Medcomm|January 7, 2025
Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanismFelix Pfister, Lucas R Carnell, Lisa Löffler, et al.
Frontiers in Immunology|February 7, 2019
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanAJan B Boscheinen, Sabrina Thomann, David M Knipe, et al.
Plos One|February 23, 2012
Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfectionManfred Lehner, Gabriel Götz, Julia Proff, et al.
Theranostics|January 4, 2021
Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapyXin Lai, Florian S Dreyer, Martina Cantone, et al.
Pageof 9